؉ cells from chronic myeloid leukemia (CML) patients proliferate in vitro in the absence of serum or defined growth factors due to an autocrine mechanism involving IL-3 and G-CSF ( 
Introduction
The chronic phase of chronic myeloid leukemia (CML) is characterized by a deregulated overproduction of neoplastic (Ph + /BCR-ABL) progenitors at intermediate stages of differentiation on all myeloid lineages (reviewed in Ref. 1) . Increased numbers of granulocyte-macrophage (CFU-GM), 2,3 erythroid (BFU-E), 4, 5 and megakaryocytic (CFU-Mk) progenitors 6,7 are typically seen in the blood of patients with elevated WBC counts. In the marrow, the frequency of these cells is within the normal range, but an overall absolute increase in their numbers can be inferred from the increased marrow cellularity. In previous studies, Ph + /BCR-ABL + progenitor cells have been reported to be growth factor-responsive. 2, [8] [9] [10] [11] They also show reduced growth factor dependence. 8, 9, 11 Some can terminally differentiate into erythroid cells and megakaryocytes in vitro in the absence of added growth factors required by normal precursors of these two lineages. 4, 6, 7, 12 However, this latter type of factor-independent terminal differentiation is not consistent for all CML patients, nor even for all of the neoplastic erythroid or megakaryocytic colony-forming cells (CFC) within a given patient. Recently, we showed that a very primitive subset of neoplastic CD34
+ cells (the CD71
CD45RA
− subset) proliferate extensively in serum-free medium to which no growth factors are added and that, under these conditions, they produce large numbers of progenitors detectable as col- ony-forming cells (CFC). 9 Further investigation revealed that Ph + /BCR-ABL CD34
+ cells produce IL-3 and G-CSF constitutively and that their abnormal autonomous growth in vitro is inhibited specifically by antibodies to IL-3 and G-CSF. 13 Paradoxically, very primitive Ph + /BCR-ABL + progenitors, identified functionally as long-term culture-initiating cells (LTC-IC), are unable to maintain their defining properties when cultured either in the presence of stroma or soluble growth factors that allow normal LTC-IC populations to be maintained or expanded. 14, 15 Taken together, these observations suggest that the autocrine mechanism displayed by very primitive CML cells may promote their differentiation, as well as stimulating their proliferation, resulting in a skewed expansion of later cell types. This concept is further supported by the observation that very primitive normal (CD34 + CD38 − ) hematopoietic cells exposed to excessive concentrations of IL-3 in vitro are similarly stimulated to proliferate with rapid loss of their original LTC-IC activity in contrast to the expansion of LTC-IC numbers obtained with concomitant stimulation by high concentrations of flt3-ligand (FL) and Steel factor (SF). 16 Since the ability of lineage-restricted CML progenitors to differentiate, per se, does not appear to be altered, we predicted that more primitive CML cells proliferating autonomously in vitro would show the full spectrum of lineage differentiation events expected from the known activities of IL-3 and G-CSF on normal progenitors. 17 A detailed and quantitative analysis of the types of cells produced in serum-free suspension cultures initiated with different subsets of CML and normal CD34 + cells in the presence or absence of various growth factor combinations was therefore undertaken. The results show for the first time that in the absence of any added growth factors, even the most primitive subsets of CD34 + CML blasts can complete differentiation programs along each of the major myeloid pathways.
Materials and methods

Cell isolation
Heparinized blood cells were obtained from seven patients with chronic phase CML (Table 1) . Normal marrow was from donors of allogeneic transplants or from cadaveric donors (North West Tissue Centre, Seattle, WA, USA). All human cell samples were obtained with informed consent. Low density (Ͻ1.077 g/ml) cells were isolated by centrifugation on FicollHypaque (Pharmacia, Piscataway, NJ, USA) and then fractionated directly, or later, after being cryopreserved in 10% DMSO plus 90% fetal calf serum (FCS). Samples were enriched for CD34
+ cells by immunomagnetic depletion of lineage marker + (lin + ) cells using StemSep columns (StemCell Technologies, Vancouver, BC) 18 and highly purified CD34 + subpopulations isolated as previously described. 9 Briefly, cells were stained with directly conjugated fluorescent antibodies + cells from blood samples from patient Nos 5-7 using exactly the same procedure as described previously. 13 The results for patient Nos 1-4 have been taken from a previous report. 13 to CD34 (8G12-Cy5), CD71 (OKT9-R-phycoerythrin (PE)) and CD45RA (8d2-R-PE) at 10 7 cells/ml for 30 min at 4°C, followed by two washes and resuspension in 2 g/ml of propidium iodide (PI, Sigma, St Louis, MO, USA) plus 0.1 g/ml of fluorescein isothiocyanate (FITC) conjugated Annexin V (BioWhittaker, LaJolla, CA, USA). Cells were sorted on a FACStar Plus equipped with a 5W argon laser and a helium neon laser (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Highly CD34
+ cells with medium to high forward light scattering and low side light scattering characteristics were further separated into subpopulations expressing different levels of CD71 and CD45RA, respectively. Cells with these phenotypes were collected in Eppendorf tubes containing serum-free medium (SFM, described below). Positive (or negative) staining was defined by a level of fluorescence that excluded (or included) at least 99% of that obtained using (irrelevant) isotype-matched control antibodies labeled with the same fluorochromes.
Cultures
Sorted CD34
+ subpopulations were diluted to 10 5 /ml in serum-free medium (SFM). This medium consisted of Iscove's medium supplemented with 20 ng/ml of BSA, 10 g/ml of human insulin and 200 g/ml of human transferrin (BIT, StemCell) with 10 −4 M 2-mercaptoethanol plus 40 g/ml low density lipoproteins (Sigma), either with or without the following combination of purified human cytokines: 20 ng/ml IL-3 (Novartis, Basel, Switzerland), 20 ng/ml G-CSF (StemCell), 20 ng/ml IL-6 (Cangene, Mississauga, ON), 100 ng/ml flt3-ligand (FL, Immunex, Seattle, WA, USA), 100 ng/ml Steel factor (SF, Amgen, Thousand Oaks, CA, USA) and 5 units/ml EPO (StemCell). Cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 in air for up to 20 days. Cell counts were made by scoring trypan blue-excluding cells in a hemocytometer. For morphological analysis, aliquots were cytospun on to slides and stained with Wright-Giemsa. For detection of intracellular CD41 expression, cytospin preparations were stained using the APAAP procedure described previously. 19 
Flow cytometry
Surface expression of the antigens CD14, CD15, CD34, CD41 and glycophorin A were evaluated using directly conjugated Leukemia FITC-or PE-conjugated monoclonal antibodies against these antigens after staining as described under Cell Isolation above. Cells were stained for intracellular ␤-globin after fixation and permeabilization as described previously. 20 Data acquisition using the FACScan and analysis was performed with PC-lysis II software (Becton Dickinson).
Progenitor assays
Cells were assayed for CFU-GM, BFU-E and CFU-E in FCScontaining methylcellulose medium (H4330, StemCell) supplemented with 50 ng/ml of FL and SF, and 20 ng/ml of IL-3, IL-6, GM-CSF (Novartis) and G-CSF, and 3 U/ml of EPO as previously described. 21 Cells were assayed for CFU-Mk on the basis of their ability to generate colonies of у3 CD41 + cells within 2 weeks of incubation at 37°C in serum-free collagen cultures (MegaCult, StemCell) containing 50 ng/ml of thrombopoietin (TPO, Genentech, San Francisco, CA, USA) and 10 ng/ml each of IL-3 and IL-6, or no growth factors, as indicated.
Results
Morphology of cells generated by purified subsets of CD34
+ CML cells cultured in the absence of exogenous growth factors
Two subpopulations of FACS-purified CD34
+ CML blood cells from patients with chronic phase disease (Table 1) were cultured in SFM with or without growth factors (as described in Materials and methods) and the cells present 10 or 20 days later analyzed. The CML patients studied included five less common patients whose most primitive progenitors (detected as LTC-IC), as well as their later hematopoietic cells (that constitute most of the remaining cells in the blood and marrow), were predominantly Ph + . Experiments with cells from these patients were specifically included in this study to ensure that the differentiation activity of the earliest types of leukemic cells cultured in the absence of added growth factors could be examined. The other two patients' cells studied were from more typical chronic phase CML patients in whom the LTC-IC compartment is dominated by residual normal (Ph − ) cells, despite a predominance of Ph + cells in the rest of the marrow and blood.
1 Table 2 shows the spectrum of morphologically recognizable cell types identified in Wright-Giemsa-stained cytospin preparations of cultures initiated 10 days previously with the two subsets of CD34 + cells studied (CD34
and CD34
+ CD71 and/or CD45RA + ). These were isolated from both categories of CML patients as well as from marrow samples obtained from two normal adults. It can be seen that by 10 days, both normal and Ph + CD34 + cells generated comparably large numbers of maturing blood cells of all the major myeloid lineages when a combination of FL, SF, IL-3, IL-6, G-CSF and EPO was added to the culture medium. This resulted in a 15-to 20-fold net cell expansion when EPO was not added and a 25-to 70-fold net cell expansion when EPO was included, the larger expansion being obtained from the CD34
+ input population. The predominant cell types in cultures to which EPO was not added were members of the granulocyte-monocyte-macrophage lineage. Most of the granulocytes belonged to the neutrophil series, but occasional basophils, particularly in the CML cultures, were also identified. In most cases, very few erythroblasts were seen when EPO was not added. The exception to this was the small but clearly detectable erythroblast population produced in cultures initiated with CD34 + CD71/CD45RA + CML cells which were stimulated by the five growth factors but not EPO. Both normal and CML cultures also produced large numbers of small (early) and large (late) megakaryocytes, particularly in cultures initiated with CD34
+ cells and stimulated with EPO as well as the five growth factor cocktail ( Figure 1) . In most cultures, undifferentiated blasts (which made up the entire input populations, eg Figure 1a) were also maintained at high enough levels to allow their continued detection in 10 day cultures, although typically at lower levels in the CML cultures by comparison to parallel cultures of normal cells.
In the absence of any added growth factors (except the insulin present in the serum substitute used), normal cells did not survive. Thus after 10 days, these cultures did not contain any cells that could be morphologically assessed. However, as reported previously, 9,13 this was not the case for the cultures of CML cells. In the cultures initiated with cells from patients who had predominantly Ph − LTC-IC, a net cell expansion of у4-fold occurred, regardless of the subset of CD34
+ cells originally placed in vitro ( Table 2 ). In the cultures initiated with cells from CML patients with exclusively Ph + cells at all stages of development within the CD34 + compartment, the net cell amplification was even greater. and large numbers of megakaryocytes also seen ( Table 2 , and Figures 1 and 2) . A persisting population of blasts was also present in most of these CML cultures but the numbers of these were decreased at least two-fold below the input value.
Further amplification of the total cell population occurred when the CML cultures were maintained for another 10 days without exogenously added growth factors and the distributions of cell types in the day 20 cultures remained generally similar to the day 10 CML culture values. However, by the end of 20 days, the blast population had largely disappeared and the population of monocytes seen in the day 10 culture was replaced by a larger number of macrophages (Table 2 and Figure 1 ).
Lin
+ antigen expression on cells produced by purified subsets of CD34 + CML cells cultured in the absence of exogenous growth factors
Separate aliquots of cells from the same cultures examined morphologically were also stained and analyzed for expression of a variety of lin-specific markers. This included an analysis of surface CD14 and CD15 expression (markers of granulocyte/macrophage differentiation), surface and intracellular CD41 expression (a specific marker of megakaryocyte differentiation), and surface glycophorin A and intracellular ␤-Leukemia globin expression (both specific markers of maturing erythroblasts). Expression of CD34 (an antigen that is characteristically lost when cells exit from the blast compartment) was also studied. The results for all of the day 10 analyses are shown in Table 3 , and for the CD41 staining of the day 10 and day 20 cultures in Figures 2 and 3 . These corroborate the findings from the morphological studies. Thus, independent of whether growth factors were added, there was a maintenance, sometimes with a small net amplification, of the CD34 + population in all cultures initiated with the more primitive subset of CD34 + cells from CML patients. However, this was less marked than the factor-stimulated amplification of analogous primitive normal CD34 + cells. In cultures initiated with the more mature (CD71/CD45RA + ) CD34
+ cells, the number of CD34 + cells present after 10 days was generally lower in both normal and CML cultures.
Consistent with the results of the morphological studies, large numbers of cells expressing markers of granulocytemacrophage differentiation (CD14 + and CD15 + ) and some expressing markers of megakaryocyte differentiation (CD41 + ) were also detected in the CML cultures, irrespective of growth factor addition (Table 3, Figures 2 and 3) . In contrast, such cells were seen in cultures of normal marrow cells only when growth factors were provided (Table 3) . Similarly, the number of glycophorin A + (and ␤-globin + ) cells present generally mirrored the numbers of morphologically recognizable 
CD45RA
− cells than in those generated by the CD34 + CD71/CD45RA + cells. EPO-independent maturation of erythroblasts in the cultures of CD34 + CML cells was also confirmed by both glycophorin A and ␤-globin staining particularly in the cultures initiated with the latter (CD71/CD45RA + ) subset (Table 3) .
In vitro generation of factor-independent, lineagerestricted CML cells capable of proliferating and differentiating in semi-solid media
The ability of different subsets of CD34 + cells from CML patients to generate specific types of CFC in the presence and absence of exogenously provided growth factors in short term serum-free cultures was also examined. Results for CFU-E, BFU-E and CFU-GM assayed in FCS-supplemented methylcellulose cultures containing SF, IL-3, IL-6, G-CSF, GM-CSF and EPO are shown in Figure 4 . Corresponding data from methylcellulose assays not containing EPO are shown in Figure 5 . Results for CFU-Mk assayed in serum-free collagen cultures containing IL-3, IL-6 and TPO, or no growth factors, are shown in Figure 6 . In each case, results from parallel cultures initiated with analogous populations of normal cells are also shown for comparison.
The frequency of CFC (assessed in methylcellulose with added growth factors) in both of the CD34 + subpopulations isolated from four CML patients (all with predominantly Ph + LTC-IC) was, on average, similar to that seen in the corre-
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sponding CD34
+ subsets obtained from the two normal marrow samples (Figure 4) . However, as seen in the liquid cultures, erythroid progenitors from CML patients were able to generate colonies of hemoglobinized erythroblasts in the absence of EPO, whereas normal cells were not ( Figure 5 ). The presence of EPO in the methylcellulose assays, however, had no effect on the detection of CFU-GM from either source. In the liquid suspension cultures, the output of CFU-E, BFU-E and CFU-GM for the first 3 days was similar for both normal and CML cells when growth factors were present. This situation persisted to day 10 for the CFU-GM but, by that time, CFU-E numbers had increased more in the cultures initiated with leukemic CD34
− cells than in the analogous normal cell cultures. At the same time, all other erythroid progenitor yields were lower in the CML cultures than in the corresponding normal cell cultures (Figure 4) . When growth factors were not added to the liquid suspension cultures of CML cells, all types of CFC were still produced. These included large numbers of CFU-GM as well as CFU-E and BFU-E that could subsequently proliferate and differentiate in semi-solid medium into colonies of erythroblasts either in the presence or absence of EPO ( Figure 5 ). As expected, in the absence of growth factors all CFC rapidly disappeared when normal CD34 + cells were cultured under serum-free conditions. 9 Generation of CFU-Mk (of both high and low proliferative capacity) in cultures initiated with either CD34
+ CML cells was also documented. For these measurements, aliquots of cells were plated in serum-free collagen assays with or without added growth factors (as described in the Methods) to allow the specific detection of the CD41
+ clonal progeny of each CFU-Mk plated. As can be seen in Figure 6 , neither the initial generation of CFU-Mk from more primitive CD34
+ CML precursors in serum-free liquid cultures, nor their subsequent differentiation into colonies of CD41 + cells required the addition of growth factors.
Discussion
In previous studies, an ability of primitive CML cells to survive and proliferate in vitro in either serum-containing or SFM to which no other growth factors are added has been demonstrated by several groups. 8, 9, 11, 13 In retrospect, these observations can be considered to have been heralded by even earlier studies documenting the ability of some erythroid CML progenitors to bypass the normal requirement for stimulation by EPO to complete the erythroid differentiation program. 4 However, most of the early reports of factor-independent proliferation and differentiation of CML-derived myeloid and megakaryocytic cells in vitro are difficult to interpret since they were done under undefined conditions and where endogenous production by other cells of factors that stimulate normal precursors is likely to have occurred. 6, 7, 10, 22 Thus the extent of autonomy of CML progenitors at different stages if differentiation has remained controversial. To circumvent this problem, we cultured highly purified subpopulations of CD34 + cells and analyzed the progression of cells through different stages of differentiation along four different lineages using assays specific for each compartment assessed. Analysis of normal CD34 + cells cultured under these conditions confirmed that exogenous growth factors are absolutely required for the generation or even maintenance of detectable numbers of CFC or more differentiated cells of any type. In marked 
contrast, highly purified CD34
+ CML cells proliferate in SFM without any exogenous growth factors and exhibit the same spectrum and extent of differentiation as is seen when a combination of FL, SF, IL-3, IL-6 and G-CSF is added. The only effect of adding these growth factors is to increase modestly the number of differentiated cells produced, particularly as they reach the final stages of maturation. These findings thus provide the first definitive evidence of the rapid, complete and multi-lineage differentiation of a very primitive subset of CD34 + CML cells proliferating autonomously in vitro. The observation that the production of the most mature cell types is more sensitive to exogenous growth factor provision is consistent with the observed decline in autocrine growth factor production in the terminally differentiating (CD34 − ) compartment. 13 Interestingly, the types of differentiated cells produced by CD34
+ CML cells cultured in the absence of growth factors was found to be similar to what is seen when analogous normal CD34
+ cells are cultured with FL, SF, IL-3, IL-6 and G-CSF. This potent combination of growth factors was previously shown to optimize the expansion within 10 days of hematopoietic cells with LTC-IC (and CFC) activity from a small starting population of normal adult CD34 +
CD38
− cells cultured in SFM. 15, 16 Therefore, although not redocumented here, it is likely that the LTC-IC and CFC in the presently described cultures of normal CD34
+ cells were similarly expanded since the subset of CD34 +
− cells is contained within the 23 For the same reason, the highly differentiated cells also apparent within 10 days in cultures initiated with normal CD34
− cells are likely to represent the progeny of more differentiated, CD34 +
+ progenitors that do not yet express detectable levels of CD71 or CD45RA. When CML (Ph + ) cells are cultured, the input Ph + LTC-IC activity is rapidly lost regardless of the growth stimulus provided, 14, 15 even though CFC numbers are concomitantly (but transiently) amplified. 9, 13 The present studies show that this is accompanied by a rapid accumulation of more differentiated cells of multiple lineages. Moreover, the kinetics of this response appears to be relatively insensitive to the addition of growth factors that are required by normal cells. This would suggest that the rapid loss of LTC-IC activity typical of cultured CML cells may also reflect an enhanced propensity of primitive CML cells to differentiate into later progenitor types with more restricted activities. Experiments with single cell cultures of highly enriched populations of Ph + /BCR-ABL + LTC-IC will be required to address this question more directly. Unfortunately, the infrequency of suitable patient samples for such studies has precluded their initiation to date.
An unexpected finding here was the extent of megakaryopoiesis obtained in cultures of CML cells without added growth factors. This could be readily documented both in liquid and semi-solid assays by both morphological analysis and specific staining of CD41 + cells and colonies. The use of Figure 4 . In this case, the CFC assays were performed in standard methylcellulose assays which contained other growth factors but no EPO. Values shown are the mean ± s.e.m. a defined serum substitute which minimizes the content of TGF-␤ in the medium is one factor that is likely to have increased the yields of maturing Mk cells, as megakaryocytopoiesis is known to be highly sensitive to the inhibitory action of this cytokine. 24 The multilineage expansion of all types of CML CFC, including CFU-Mk, observed here mirrors that seen in CML patients. Moreover, the ability of the neoplastic CFUMk to differentiate autonomously provides a potential explanation for the increased output of platelets that frequently accompanies an uncontrolled expansion of the CML clone in vivo.
In a previous study we showed that Ph + CD34 + cells produce bioactive levels of IL-3 and G-CSF and that their capacity for autonomous proliferation in vitro under the same conditions used here can be significantly inhibited by addition of antibodies that inhibit the activity of these two factors. 13 In the present work, some of the studies were performed with samples from four of the patients included in this earlier report. The other cells used here were from three other patients not previously studied. However, constitutive expression of IL-3 and G-CSF mRNA by the CD34 + cells from each of these additional patients was also demonstrated (Table 1) . Thus, all samples showed biochemical as well as biological evidence of an autocrine mechanism. Both IL-3 and G-CSF are known to be potent stimulators of granulopoiesis, megakaryocytopoiesis and early stages of erythropoiesis by normal hematopoietic cells in vitro. 17 Thus their constitutive Leukemia production by CML CD34 + cells provides the most likely explanation for the differentiative behavior now documented for these cells in SFM. (More direct evidence would be difficult to obtain since inhibition of the autocrine IL-3/G-CSF mechanism results in failure of these cells to be sustained 13 ). In vivo, where growth factor levels are likely to be minimal, the autocrine activities of CML cells would be anticipated to give them a significant and selective but lineage-unrestricted advantage at the post-LTC-IC stage. This is, in fact, exactly the pattern of progenitor expansion that is generally observed in CML patients with a preferential amplification of granulocyte output occurring only at the point of terminal precursor cell differentiation.
It should be noted that in another recent report, constitutive expression of GM-CSF production by cells from chronic phase CML patients was reported and addition of anti-GM-CSF antibodies neutralized the spontaneous megakaryocyte colony formation seen when these cells were assayed in vitro. 25 However, these experiments were not undertaken with highly purified cells and the assays were not performed under SFM conditions. Therefore, the precise origin of the GM-CSF and the potential role of factors present in the human plasma added to the assays could not be established. In our studies, highly sensitive RT-PCR analysis of purified CD34 + cells from CML patients has not shown GM-CSF transcripts to be present in these cells 13 suggesting an indirect origin of any GM-CSF produced in cultures of less purified cells. In these same studies,
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Figure 6
Production of CFU-Mk in cultures of CD34 we showed that SF, IL-6 and TPO are not produced by CD34 + CML cells from chronic phase patients.
In summary, we have demonstrated a consistent, lineageunrestricted, factor-independent production and differentiation of CML progenitors in serum-free cultures of different subsets of CD34 + cells. This activity is consistent with and predicted by an autocrine mechanism involving the constitutive production by these cells of IL-3 and G-CSF (but not SF, GM-CSF, IL-6 or TPO) which declines as they exit the CD34 + cell compartment. Future studies with model systems may help to delineate how the BCR-ABL oncoprotein contributes to this unique biology of CML hematopoiesis.
